Qiming U.s. Ventures Management, LLC

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
6
Total Value
23102786
Accession Number
0001415889-25-013135
Form Type
13F-HR
Manager Name
Qiming-Us-Ventures-Management
Data Enrichment
100% identified
6 identified0 unidentified

Holdings

6 positions
Manager:
Search and click to pin securities to the top
Tourmaline Bio, Inc.
Shares:741.7K
Value:$11.3M
Korro Bio, Inc.
Shares:368.1K
Value:$6.4M
Jasper Therapeutics, Inc.
Shares:929.0K
Value:$4.0M
HilleVax, Inc.
Shares:372.6K
Value:$540.3K
Ventyx Biosciences, Inc.
Shares:412.2K
Value:$474.1K
Kezar Life Sciences, Inc.
Shares:82.9K
Value:$404.4K